| 2024-03-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance, CFO | 10,121 0.0105% | $65.96 | $667,587 | +3.8% | |
| 2024-03-07 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance, CFO | 13,132 0.0135% | $66.60 | $874,560 | +1.83% | |
| 2024-02-26 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance, CFO | 13,337 0.0134% | $69.43 | $925,961 | -5.04% | |
| 2024-02-02 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance, CFO | 11,183 0.0113% | $66.62 | $745,037 | +1.75% | |
| 2023-06-14 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 81,854 0.0855% | $63.97 | $5.24M | +0.87% | |
| 2023-03-13 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 5,582 0.0058% | $44.93 | $250,808 | +35.93% | |
| 2023-03-13 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 5,324 0.0056% | $44.97 | $239,420 | +35.93% | |
| 2023-03-10 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 15,663 0.0161% | $43.06 | $674,417 | +38.64% | |
| 2023-03-10 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 12,963 0.0134% | $43.17 | $559,613 | +38.64% | |
| 2023-02-24 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 7,455 0.0078% | $47.03 | $350,609 | +27.97% | |
| 2023-02-21 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 10,443 0.0111% | $46.82 | $488,891 | +29.6% | |
| 2023-02-17 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 53,968 0.0565% | $49.83 | $2.69M | +19.94% | |
| 2022-02-24 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 7,454 0.0078% | $51.97 | $387,349 | -2.17% | |
| 2022-02-22 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 10,443 0.0114% | $55.40 | $578,506 | -3.92% | |
| 2022-01-10 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 19,639 0.0211% | $40.76 | $800,420 | +29.07% | |
| 2021-12-21 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 175,000 0.2127% | $47.59 | $8.33M | +9.7% | |
| 2021-02-19 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 10,442 0.0128% | $39.23 | $409,625 | -4.23% | |
| 2021-01-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 19,638 0.0243% | $32.02 | $628,769 | +15.93% | |
| 2021-01-04 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 15,810 0.0193% | $31.31 | $495,008 | +16.63% | |
| 2020-11-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP of Finance CFO | 28,034 0.0349% | $25.41 | $712,344 | +36.75% |